Pharmacological Rationale for Targeting IL-17 in Asthma

Asthma is a respiratory disease that currently affects around 300 million people worldwide and is defined by coughing, shortness of breath, wheezing, mucus overproduction, chest tightness, and expiratory airflow limitation. Increased levels of interleukin 17 (IL-17) have been observed in sputum, nas...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmawati, Siti Farah, te Velde, Maurice, Kerstjens, Huib A. M., Dömling, Alexander S. S., Groves, Matthew Robert, Gosens, Reinoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974835/
https://www.ncbi.nlm.nih.gov/pubmed/35387016
http://dx.doi.org/10.3389/falgy.2021.694514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974835/
https://www.ncbi.nlm.nih.gov/pubmed/35387016
http://dx.doi.org/10.3389/falgy.2021.694514

Ejemplares similares